Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/27/26 17:27 | 8/20/26 | BMRA | Health | Diagn | In Vitro & In Vivo Diagnostic | Gary M. Huff | CA | D | 1 | P | 50 | 1.60 | 0 | 31 | 156 | 51 | D | |||||||||||||||
8/27/26 17:26 | 8/26/26 | BMRA | Health | Diagn | In Vitro & In Vivo Diagnostic | Moatazedi David | CA | D | 1 | P | 16 | 1.60 | 0 | 10 | 33 | 41 | D | |||||||||||||||
8/27/26 17:26 | 8/26/26 | BMRA | Health | Diagn | In Vitro & In Vivo Diagnostic | Chin Eric | CA | D | 1 | P | 10 | 1.60 | 0 | 6 | 19 | 39 | D | |||||||||||||||
8/27/26 17:24 | 8/26/26 | BMRA | Health | Diagn | In Vitro & In Vivo Diagnostic | Barbieri Allen | CA | DO | Exec Vic | 1 | P | 32 | 1.60 | 0 | 20 | 37 | 74 | D | ||||||||||||||
8/27/26 17:23 | 8/26/26 | BMRA | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | 1 | P | 50 | 1.60 | 0 | 31 | 15 | 243 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |